NCT01823198
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Blasts Under 20 Percent of Peripheral Blood White Cells
Explore clinical trials studying Blasts Under 20 Percent of Peripheral Blood White Cells. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies
Blasts Under 20 Percent of Peripheral Blood White Cells trial results
Related conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (1)
- Acute Erythroid Leukemia (1)
- Acute Megakaryoblastic Leukemia (1)
- Acute Myeloid Leukemia (1)
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome (1)
- Acute Myeloid Leukemia in Remission (1)
- Blast Crisis (1)
- Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (1)